Updates are available Erratum dated 2017-02-23
Click to view Erratum: https://doi.org/10.1007/s10157-017-1384-y
-
Authors
Chang, Yu-Ming
Tsai, Shih-Ching
Shiao, Chih-Chung
Liou, Hung-Hsiang
Yang, Chuan-Lan
Tung, Nai-Yu
Hsu, Kua-Sui
Chen, I-Ling
Liu, Mei-Chyn
Kao, Jsun-Liang
Jhen, Rong-Na
Huang, Ya-Ting
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01845090 at ClinicalTrials.govDocuments that mention this clinical trial
Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients
https://doi.org/10.1007/s10157-016-1362-9
-
Funding
Funding for this research was provided by:
Saint Mary’s Hospital Research Fund (SMHRF100004)
- License Information
-
More Information
Article History
Received: 4 August 2016
Accepted: 23 November 2016
First Online: 7 December 2016
Change Date: 23 February 2017
Change Type: Erratum
Change Details: An erratum to this article has been published.
Compliance with ethical standards
:
: The authors have declared that no conflict of interest exists.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number SMHIRB100001) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
